Britain on Thursday cautioned the public about buying fake weight-loss pens claiming to contain Novo Nordisk’s diabetes drug Ozempic or weight-loss drug Saxenda after reports of a “very small number” of hospitalizations. The warning from the country’s medicines regulator comes …
European authorities are investigating whether popular weight-loss and diabetes drugs including Novo Nordisk A/S’s Wegovy may be linked to complications during anesthesia. The European Medicines Agency’s safety committee, PRAC, is discussing the potential safety issue during its meeting this week. …
Eli Lilly & Co. is suing medical spas, wellness centers and compounding pharmacies in various US states that sell unapproved versions of its blockbuster diabetes drug Mounjaro, which is frequently used off-label for weight loss. In lawsuits Lilly said it …
The European Union’s drug regulator expanded its investigation into a possible risk of suicidal thoughts associated with a new class of weight-loss medicines and a separate analysis found that most patients stopped taking the medications after a year. The European …
The European Medicines Agency (EMA) is probing Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three cases of patients on the drugs thinking about suicide or self-harm. Shares of the Danish drugmaker fell about …
Danish insulin-maker Novo Nordisk said it would fight a lawsuit filed in a Danish court on Friday which alleges the company made misleading statements about its insulin business in the United States, the company said in a statement. “Novo Nordisk …
Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent – but the tactic is doing little to salve critics, including President-elect Donald Trump, who on Wednesday …
